Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX)

Context Therapeutics Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are both Biotechnology companies. Context Therapeutics Inc. and Quoin Pharmaceuticals, Ltd. Sponsored ADR are of similar size ($18.5M and $17.3M). Across the 8 metrics below, Context Therapeutics Inc. leads on 5 and Quoin Pharmaceuticals, Ltd. Sponsored ADR on 3.

Valuation

Metric CNTX QNRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.47 2.63 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.51 n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (252.63%) (331.86%) (32.88%)
Free cash flow yield (188.15%) (27.69%) (23.13%)

Profitability

Metric CNTX QNRX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) (575.73%) (51.96%)
Return on assets (68.96%) (178.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTX QNRX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 17.39% 77.84% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX QNRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 1.76 4.97
Net debt to EBITDA 1.66 1.16 1.01

Dividend

Metric CNTX QNRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTX QNRX Biotechnology median
Market cap 17.27m 18.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack